We are flexible

Although we perform the standard studies needed to document the effect of new drug candidates we are always interested in adding new effect models to our portfolio. In the development of effect models our extensive experience in pharmacology and physiology is fully utilized.
;

The standard services are:

  • DMPK
  • Toxicity studies:
    • Acute administration
    • Repeated administration
  • Haematology
  • Clinical chemistry
  • Histopathology
?

We perform effect models, especially in:

  • Cancer
  • Inflammation
  • SARS-CoV-2 infected ACE2 mice and ferrets
P

We also perform:

  • Biocompatibility studies
  • Surgical interventions
  • Studies which require P2 or P3 containment

Behavioural studies:

  • Irwin screen
  • RotaRod

Catheterizations for:

  • BP and heart rate
  • Urinary and biliary excretion

We have access to equipment for:

  • Angiography
  • micro PET
  • nanoScan PET-MRI/CT
  • 9.4 Varian MRI
  • IVIS

Adlego Biomedical AB
Box 42
751 03
Uppsala
Sweden

Tel: + 46 (0)733 42 17 37
Email: [email protected]
© 2021 Adlego SE
Site by: Camelotweb